HEADER DE NOVO PROTEIN 29-MAY-07 2Q33 TITLE CRYSTAL STRUCTURE OF ALL-D MONELLIN AT 1.8 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-MONELLIN CHAIN A; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: MONELLIN CHAIN I; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: D-MONELLIN CHAIN B; COMPND 8 CHAIN: B; COMPND 9 SYNONYM: MONELLIN CHAIN II; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THE ENANTIOMERIC PROTEIN WAS CHEMICALLY SYNTHESIZED SOURCE 4 WITH ALL D-AMINO ACIDS. THE SEQUENCE OF THE PROTEIN IS NATURALLY SOURCE 5 FOUND IN DIOSCOREOPHYLLUM CUMMINSII.; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 OTHER_DETAILS: THE ENANTIOMERIC PROTEIN WAS CHEMICALLY SYNTHESIZED SOURCE 9 WITH ALL D-AMINO ACIDS. THE SEQUENCE OF THE PROTEIN IS NATURALLY SOURCE 10 FOUND IN DIOSCOREOPHYLLUM CUMMINSII. KEYWDS ALPHA/BETA, ALL-D PROTEIN, DE NOVO PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR L.-W.HUNG,M.KOHMURA,Y.ARIYOSHI,S.-H.KIM REVDAT 3 18-OCT-17 2Q33 1 REMARK REVDAT 2 24-FEB-09 2Q33 1 VERSN REVDAT 1 13-NOV-07 2Q33 0 SPRSDE 13-NOV-07 2Q33 1N98 JRNL AUTH L.-W.HUNG,M.KOHMURA,Y.ARIYOSHI,S.-H.KIM JRNL TITL STRUCTURE OF AN ENANTIOMERIC PROTEIN, D-MONELLIN AT 1.8 A JRNL TITL 2 RESOLUTION. JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 54 494 1998 JRNL REFN ISSN 0907-4449 JRNL PMID 9867435 JRNL DOI 10.1107/S0907444997012225 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 735264.360 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 87.7 REMARK 3 NUMBER OF REFLECTIONS : 8665 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.600 REMARK 3 FREE R VALUE TEST SET COUNT : 919 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.91 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 71.20 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1040 REMARK 3 BIN R VALUE (WORKING SET) : 0.2430 REMARK 3 BIN FREE R VALUE : 0.3230 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.20 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 118 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.030 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 754 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 82 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 13.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.67000 REMARK 3 B22 (A**2) : 0.21000 REMARK 3 B33 (A**2) : 0.46000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.89000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.19 REMARK 3 ESD FROM SIGMAA (A) : 0.19 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.23 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.22 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.500 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.60 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.300 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.990 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.270 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.480 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 5.290 ; 2.500 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE PROTEIN WAS CHEMICALLY SYNTHESIZED REMARK 3 WITH ALL D-AMINO ACIDS. THIS STRUCTURE WAS DETERMINED AND REMARK 3 REFINED WITH L-AMINO ACID PARAMETERS. THE ACTUAL ASYMMETRIC UNIT REMARK 3 SHOULD CONTAIN THE PROTEIN REPRESENTED BY THIS COORDINATE FILE. REMARK 4 REMARK 4 2Q33 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-JUN-07. REMARK 100 THE DEPOSITION ID IS D_1000043087. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-SEP-94 REMARK 200 TEMPERATURE (KELVIN) : 277.0 REMARK 200 PH : 7.20 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.08 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : SYNCHROTRON REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9511 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 35.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.0 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : 70.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.59 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20 MM SODIUM PHOSPHATE BUFFER, 28% PEG REMARK 280 8000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K, PH 7.20 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2620 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 127 LIES ON A SPECIAL POSITION. REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 DSG B 35 65.77 104.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE L-AMINO VERSION OF THE PROTEINS IN CHAINS A AND B REMARK 999 CORRESPOND TO THE SEQUENCES IN UNP ENTRIES MONA_DIOCU REMARK 999 AND MONB_DIOCU RESPECTIVELY DBREF 2Q33 A 52 94 PDB 2Q33 2Q33 1 43 DBREF 2Q33 B 1 48 PDB 2Q33 2Q33 1 48 SEQRES 1 A 43 DGL DIL DLY GLY DTY DGL DTY DGN DLE DTY DVA DTY DAL SEQRES 2 A 43 DSN DAS DLY DLE DPN DAR DAL DAS DIL DSN DGL DAS DTY SEQRES 3 A 43 DLY DTH DAR GLY DAR DLY DLE DLE DAR DPN DSG GLY DPR SEQRES 4 A 43 DVA DPR DPR DPR SEQRES 1 B 48 GLY DGL DTR DGL DIL DIL DAS DIL GLY DPR DPN DTH DGN SEQRES 2 B 48 DSG DLE GLY DLY DPN DAL DVA DAS DGL DGL DSG DLY DIL SEQRES 3 B 48 GLY DGN DTY GLY DAR DLE DTH DPN DSG DLY DVA DIL DAR SEQRES 4 B 48 DPR DCY MED DLY DLY DTH DIL DTY DGL MODRES 2Q33 DGL A 52 GLU D-GLUTAMIC ACID MODRES 2Q33 DIL A 53 ILE D-ISOLEUCINE MODRES 2Q33 DLY A 54 LYS D-LYSINE MODRES 2Q33 DTY A 56 TYR D-TYROSINE MODRES 2Q33 DGL A 57 GLU D-GLUTAMIC ACID MODRES 2Q33 DTY A 58 TYR D-TYROSINE MODRES 2Q33 DGN A 59 GLN D-GLUTAMINE MODRES 2Q33 DLE A 60 LEU D-LEUCINE MODRES 2Q33 DTY A 61 TYR D-TYROSINE MODRES 2Q33 DVA A 62 VAL D-VALINE MODRES 2Q33 DTY A 63 TYR D-TYROSINE MODRES 2Q33 DAL A 64 ALA D-ALANINE MODRES 2Q33 DSN A 65 SER D-SERINE MODRES 2Q33 DAS A 66 ASP D-ASPARTIC ACID MODRES 2Q33 DLY A 67 LYS D-LYSINE MODRES 2Q33 DLE A 68 LEU D-LEUCINE MODRES 2Q33 DAR A 70 ARG D-ARGININE MODRES 2Q33 DAL A 71 ALA D-ALANINE MODRES 2Q33 DAS A 72 ASP D-ASPARTIC ACID MODRES 2Q33 DIL A 73 ILE D-ISOLEUCINE MODRES 2Q33 DSN A 74 SER D-SERINE MODRES 2Q33 DGL A 75 GLU D-GLUTAMIC ACID MODRES 2Q33 DAS A 76 ASP D-ASPARTIC ACID MODRES 2Q33 DTY A 77 TYR D-TYROSINE MODRES 2Q33 DLY A 78 LYS D-LYSINE MODRES 2Q33 DTH A 79 THR D-THREONINE MODRES 2Q33 DAR A 80 ARG D-ARGININE MODRES 2Q33 DAR A 82 ARG D-ARGININE MODRES 2Q33 DLY A 83 LYS D-LYSINE MODRES 2Q33 DLE A 84 LEU D-LEUCINE MODRES 2Q33 DLE A 85 LEU D-LEUCINE MODRES 2Q33 DAR A 86 ARG D-ARGININE MODRES 2Q33 DSG A 88 ASN D-ASPARAGINE MODRES 2Q33 DPR A 90 PRO D-PROLINE MODRES 2Q33 DVA A 91 VAL D-VALINE MODRES 2Q33 DPR A 92 PRO D-PROLINE MODRES 2Q33 DPR A 93 PRO D-PROLINE MODRES 2Q33 DPR A 94 PRO D-PROLINE MODRES 2Q33 DGL B 2 GLU D-GLUTAMIC ACID MODRES 2Q33 DTR B 3 TRP D-TRYPTOPHAN MODRES 2Q33 DGL B 4 GLU D-GLUTAMIC ACID MODRES 2Q33 DIL B 5 ILE D-ISOLEUCINE MODRES 2Q33 DIL B 6 ILE D-ISOLEUCINE MODRES 2Q33 DAS B 7 ASP D-ASPARTIC ACID MODRES 2Q33 DIL B 8 ILE D-ISOLEUCINE MODRES 2Q33 DPR B 10 PRO D-PROLINE MODRES 2Q33 DTH B 12 THR D-THREONINE MODRES 2Q33 DGN B 13 GLN D-GLUTAMINE MODRES 2Q33 DSG B 14 ASN D-ASPARAGINE MODRES 2Q33 DLE B 15 LEU D-LEUCINE MODRES 2Q33 DLY B 17 LYS D-LYSINE MODRES 2Q33 DAL B 19 ALA D-ALANINE MODRES 2Q33 DVA B 20 VAL D-VALINE MODRES 2Q33 DAS B 21 ASP D-ASPARTIC ACID MODRES 2Q33 DGL B 22 GLU D-GLUTAMIC ACID MODRES 2Q33 DGL B 23 GLU D-GLUTAMIC ACID MODRES 2Q33 DSG B 24 ASN D-ASPARAGINE MODRES 2Q33 DLY B 25 LYS D-LYSINE MODRES 2Q33 DIL B 26 ILE D-ISOLEUCINE MODRES 2Q33 DGN B 28 GLN D-GLUTAMINE MODRES 2Q33 DTY B 29 TYR D-TYROSINE MODRES 2Q33 DAR B 31 ARG D-ARGININE MODRES 2Q33 DLE B 32 LEU D-LEUCINE MODRES 2Q33 DTH B 33 THR D-THREONINE MODRES 2Q33 DSG B 35 ASN D-ASPARAGINE MODRES 2Q33 DLY B 36 LYS D-LYSINE MODRES 2Q33 DVA B 37 VAL D-VALINE MODRES 2Q33 DIL B 38 ILE D-ISOLEUCINE MODRES 2Q33 DAR B 39 ARG D-ARGININE MODRES 2Q33 DPR B 40 PRO D-PROLINE MODRES 2Q33 DCY B 41 CYS D-CYSTEINE MODRES 2Q33 MED B 42 MET D-METHIONINE MODRES 2Q33 DLY B 43 LYS D-LYSINE MODRES 2Q33 DLY B 44 LYS D-LYSINE MODRES 2Q33 DTH B 45 THR D-THREONINE MODRES 2Q33 DIL B 46 ILE D-ISOLEUCINE MODRES 2Q33 DTY B 47 TYR D-TYROSINE MODRES 2Q33 DGL B 48 GLU D-GLUTAMIC ACID HET DGL A 52 9 HET DIL A 53 8 HET DLY A 54 9 HET DTY A 56 12 HET DGL A 57 9 HET DTY A 58 12 HET DGN A 59 9 HET DLE A 60 8 HET DTY A 61 12 HET DVA A 62 7 HET DTY A 63 12 HET DAL A 64 5 HET DSN A 65 6 HET DAS A 66 8 HET DLY A 67 9 HET DLE A 68 8 HET DPN A 69 11 HET DAR A 70 11 HET DAL A 71 5 HET DAS A 72 8 HET DIL A 73 8 HET DSN A 74 6 HET DGL A 75 9 HET DAS A 76 8 HET DTY A 77 12 HET DLY A 78 9 HET DTH A 79 7 HET DAR A 80 11 HET DAR A 82 11 HET DLY A 83 9 HET DLE A 84 8 HET DLE A 85 8 HET DAR A 86 11 HET DPN A 87 11 HET DSG A 88 8 HET DPR A 90 7 HET DVA A 91 7 HET DPR A 92 7 HET DPR A 93 7 HET DPR A 94 7 HET DGL B 2 9 HET DTR B 3 14 HET DGL B 4 9 HET DIL B 5 8 HET DIL B 6 8 HET DAS B 7 8 HET DIL B 8 8 HET DPR B 10 7 HET DPN B 11 11 HET DTH B 12 7 HET DGN B 13 9 HET DSG B 14 8 HET DLE B 15 8 HET DLY B 17 9 HET DPN B 18 11 HET DAL B 19 5 HET DVA B 20 7 HET DAS B 21 8 HET DGL B 22 9 HET DGL B 23 9 HET DSG B 24 8 HET DLY B 25 9 HET DIL B 26 8 HET DGN B 28 9 HET DTY B 29 12 HET DAR B 31 11 HET DLE B 32 8 HET DTH B 33 7 HET DPN B 34 11 HET DSG B 35 8 HET DLY B 36 9 HET DVA B 37 7 HET DIL B 38 8 HET DAR B 39 11 HET DPR B 40 7 HET DCY B 41 6 HET MED B 42 8 HET DLY B 43 9 HET DLY B 44 9 HET DTH B 45 7 HET DIL B 46 8 HET DTY B 47 12 HET DGL B 48 9 HETNAM DGL D-GLUTAMIC ACID HETNAM DIL D-ISOLEUCINE HETNAM DLY D-LYSINE HETNAM DTY D-TYROSINE HETNAM DGN D-GLUTAMINE HETNAM DLE D-LEUCINE HETNAM DVA D-VALINE HETNAM DAL D-ALANINE HETNAM DSN D-SERINE HETNAM DAS D-ASPARTIC ACID HETNAM DPN D-PHENYLALANINE HETNAM DAR D-ARGININE HETNAM DTH D-THREONINE HETNAM DSG D-ASPARAGINE HETNAM DPR D-PROLINE HETNAM DTR D-TRYPTOPHAN HETNAM DCY D-CYSTEINE HETNAM MED D-METHIONINE FORMUL 1 DGL 8(C5 H9 N O4) FORMUL 1 DIL 8(C6 H13 N O2) FORMUL 1 DLY 9(C6 H14 N2 O2) FORMUL 1 DTY 7(C9 H11 N O3) FORMUL 1 DGN 3(C5 H10 N2 O3) FORMUL 1 DLE 6(C6 H13 N O2) FORMUL 1 DVA 4(C5 H11 N O2) FORMUL 1 DAL 3(C3 H7 N O2) FORMUL 1 DSN 2(C3 H7 N O3) FORMUL 1 DAS 5(C4 H7 N O4) FORMUL 1 DPN 5(C9 H11 N O2) FORMUL 1 DAR 6(C6 H15 N4 O2 1+) FORMUL 1 DTH 4(C4 H9 N O3) FORMUL 1 DSG 4(C4 H8 N2 O3) FORMUL 1 DPR 6(C5 H9 N O2) FORMUL 2 DTR C11 H12 N2 O2 FORMUL 2 DCY C3 H7 N O2 S FORMUL 2 MED C5 H11 N O2 S FORMUL 3 HOH *82(H2 O) HELIX 1 1 GLY B 9 GLY B 27 1 19 SHEET 1 A 5 DAR A 82 DSG A 88 0 SHEET 2 A 5 DLY A 67 DAS A 76 -1 N DAS A 72 O DLE A 85 SHEET 3 A 5 DIL A 53 DAL A 64 -1 N DLE A 60 O DAL A 71 SHEET 4 A 5 DPN B 34 DTY B 47 -1 O DLY B 36 N DTY A 63 SHEET 5 A 5 DGL B 4 DIL B 6 -1 N DIL B 6 O DCY B 41 LINK C DGL A 52 N DIL A 53 1555 1555 1.34 LINK C DIL A 53 N DLY A 54 1555 1555 1.32 LINK C DLY A 54 N GLY A 55 1555 1555 1.33 LINK C GLY A 55 N DTY A 56 1555 1555 1.32 LINK C DTY A 56 N DGL A 57 1555 1555 1.33 LINK C DGL A 57 N DTY A 58 1555 1555 1.33 LINK C DTY A 58 N DGN A 59 1555 1555 1.33 LINK C DGN A 59 N DLE A 60 1555 1555 1.33 LINK C DLE A 60 N DTY A 61 1555 1555 1.33 LINK C DTY A 61 N DVA A 62 1555 1555 1.32 LINK C DVA A 62 N DTY A 63 1555 1555 1.33 LINK C DTY A 63 N DAL A 64 1555 1555 1.33 LINK C DAL A 64 N DSN A 65 1555 1555 1.33 LINK C DSN A 65 N DAS A 66 1555 1555 1.33 LINK C DAS A 66 N DLY A 67 1555 1555 1.33 LINK C DLY A 67 N DLE A 68 1555 1555 1.32 LINK C DLE A 68 N DPN A 69 1555 1555 1.34 LINK C DPN A 69 N DAR A 70 1555 1555 1.32 LINK C DAR A 70 N DAL A 71 1555 1555 1.32 LINK C DAL A 71 N DAS A 72 1555 1555 1.34 LINK C DAS A 72 N DIL A 73 1555 1555 1.33 LINK C DIL A 73 N DSN A 74 1555 1555 1.34 LINK C DSN A 74 N DGL A 75 1555 1555 1.32 LINK C DGL A 75 N DAS A 76 1555 1555 1.32 LINK C DAS A 76 N DTY A 77 1555 1555 1.33 LINK C DTY A 77 N DLY A 78 1555 1555 1.33 LINK C DLY A 78 N DTH A 79 1555 1555 1.32 LINK C DTH A 79 N DAR A 80 1555 1555 1.33 LINK C DAR A 80 N GLY A 81 1555 1555 1.33 LINK C GLY A 81 N DAR A 82 1555 1555 1.33 LINK C DAR A 82 N DLY A 83 1555 1555 1.33 LINK C DLY A 83 N DLE A 84 1555 1555 1.33 LINK C DLE A 84 N DLE A 85 1555 1555 1.33 LINK C DLE A 85 N DAR A 86 1555 1555 1.32 LINK C DAR A 86 N DPN A 87 1555 1555 1.32 LINK C DPN A 87 N DSG A 88 1555 1555 1.33 LINK C DSG A 88 N GLY A 89 1555 1555 1.32 LINK C GLY A 89 N DPR A 90 1555 1555 1.34 LINK C DPR A 90 N DVA A 91 1555 1555 1.33 LINK C DVA A 91 N DPR A 92 1555 1555 1.34 LINK C DPR A 92 N DPR A 93 1555 1555 1.34 LINK C DPR A 93 N DPR A 94 1555 1555 1.34 LINK C GLY B 1 N DGL B 2 1555 1555 1.33 LINK C DGL B 2 N DTR B 3 1555 1555 1.32 LINK C DTR B 3 N DGL B 4 1555 1555 1.33 LINK C DGL B 4 N DIL B 5 1555 1555 1.32 LINK C DIL B 5 N DIL B 6 1555 1555 1.33 LINK C DIL B 6 N DAS B 7 1555 1555 1.33 LINK C DAS B 7 N DIL B 8 1555 1555 1.32 LINK C DIL B 8 N GLY B 9 1555 1555 1.33 LINK C GLY B 9 N DPR B 10 1555 1555 1.34 LINK C DPR B 10 N DPN B 11 1555 1555 1.33 LINK C DPN B 11 N DTH B 12 1555 1555 1.33 LINK C DTH B 12 N DGN B 13 1555 1555 1.32 LINK C DGN B 13 N DSG B 14 1555 1555 1.33 LINK C DSG B 14 N DLE B 15 1555 1555 1.33 LINK C DLE B 15 N GLY B 16 1555 1555 1.34 LINK C GLY B 16 N DLY B 17 1555 1555 1.33 LINK C DLY B 17 N DPN B 18 1555 1555 1.33 LINK C DPN B 18 N DAL B 19 1555 1555 1.34 LINK C DAL B 19 N DVA B 20 1555 1555 1.33 LINK C DVA B 20 N DAS B 21 1555 1555 1.33 LINK C DAS B 21 N DGL B 22 1555 1555 1.33 LINK C DGL B 22 N DGL B 23 1555 1555 1.33 LINK C DGL B 23 N DSG B 24 1555 1555 1.33 LINK C DSG B 24 N DLY B 25 1555 1555 1.34 LINK C DLY B 25 N DIL B 26 1555 1555 1.33 LINK C DIL B 26 N GLY B 27 1555 1555 1.33 LINK C GLY B 27 N DGN B 28 1555 1555 1.33 LINK C DGN B 28 N DTY B 29 1555 1555 1.33 LINK C DTY B 29 N GLY B 30 1555 1555 1.33 LINK C GLY B 30 N DAR B 31 1555 1555 1.32 LINK C DAR B 31 N DLE B 32 1555 1555 1.33 LINK C DLE B 32 N DTH B 33 1555 1555 1.33 LINK C DTH B 33 N DPN B 34 1555 1555 1.33 LINK C DPN B 34 N DSG B 35 1555 1555 1.33 LINK C DSG B 35 N DLY B 36 1555 1555 1.33 LINK C DLY B 36 N DVA B 37 1555 1555 1.33 LINK C DVA B 37 N DIL B 38 1555 1555 1.33 LINK C DIL B 38 N DAR B 39 1555 1555 1.32 LINK C DAR B 39 N DPR B 40 1555 1555 1.34 LINK C DPR B 40 N DCY B 41 1555 1555 1.33 LINK C DCY B 41 N MED B 42 1555 1555 1.33 LINK C MED B 42 N DLY B 43 1555 1555 1.32 LINK C DLY B 43 N DLY B 44 1555 1555 1.33 LINK C DLY B 44 N DTH B 45 1555 1555 1.33 LINK C DTH B 45 N DIL B 46 1555 1555 1.33 LINK C DIL B 46 N DTY B 47 1555 1555 1.33 LINK C DTY B 47 N DGL B 48 1555 1555 1.33 CISPEP 1 GLY A 89 DPR A 90 0 0.24 CISPEP 2 DAR B 39 DPR B 40 0 0.09 CRYST1 40.400 32.940 41.110 90.00 96.73 90.00 P 1 2 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024752 0.000000 0.002921 0.00000 SCALE2 0.000000 0.030358 0.000000 0.00000 SCALE3 0.000000 0.000000 0.024494 0.00000 HETATM 1 N DGL A 52 -33.394 -8.578 -5.182 1.00 62.00 N HETATM 2 CA DGL A 52 -32.824 -9.196 -6.380 1.00 60.29 C HETATM 3 C DGL A 52 -31.547 -8.516 -6.890 1.00 55.23 C HETATM 4 O DGL A 52 -31.472 -8.161 -8.061 1.00 52.64 O HETATM 5 CB DGL A 52 -32.568 -10.694 -6.153 1.00 65.42 C HETATM 6 CG DGL A 52 -33.754 -11.615 -6.458 1.00 69.79 C HETATM 7 CD DGL A 52 -33.925 -11.915 -7.948 1.00 72.15 C HETATM 8 OE1 DGL A 52 -32.946 -12.347 -8.597 1.00 71.48 O HETATM 9 OE2 DGL A 52 -35.051 -11.735 -8.464 1.00 74.16 O HETATM 10 N DIL A 53 -30.544 -8.357 -6.024 1.00 49.79 N HETATM 11 CA DIL A 53 -29.281 -7.715 -6.419 1.00 44.37 C HETATM 12 C DIL A 53 -29.359 -6.187 -6.422 1.00 37.94 C HETATM 13 O DIL A 53 -29.619 -5.562 -5.393 1.00 38.18 O HETATM 14 CB DIL A 53 -28.115 -8.103 -5.497 1.00 45.71 C HETATM 15 CG1 DIL A 53 -28.096 -9.610 -5.249 1.00 44.60 C HETATM 16 CG2 DIL A 53 -26.789 -7.666 -6.137 1.00 46.50 C HETATM 17 CD1 DIL A 53 -27.027 -10.025 -4.262 1.00 42.67 C HETATM 18 N DLY A 54 -29.149 -5.588 -7.584 1.00 32.15 N HETATM 19 CA DLY A 54 -29.193 -4.146 -7.693 1.00 29.05 C HETATM 20 C DLY A 54 -27.804 -3.553 -7.409 1.00 28.37 C HETATM 21 O DLY A 54 -27.671 -2.571 -6.661 1.00 25.03 O HETATM 22 CB DLY A 54 -29.716 -3.743 -9.079 1.00 32.79 C HETATM 23 CG DLY A 54 -29.601 -2.254 -9.409 1.00 38.37 C HETATM 24 CD DLY A 54 -30.677 -1.811 -10.375 1.00 42.80 C HETATM 25 CE DLY A 54 -32.035 -1.844 -9.688 1.00 51.28 C HETATM 26 NZ DLY A 54 -33.206 -1.742 -10.630 1.00 58.35 N